Alkermes plc Stock
Price
Target price
€22.80
€22.80
0.890%
0.2
0.890%
€37.60
08.08.25 / Stuttgart Stock Exchange
WKN: A1JKVH / Symbol: ALKS / Name: Alkermes / Stock / Biotechnology & Medical Research / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Financial data and news for Alkermes
sharewise wants to provide you with the best news and tools for Alkermes, so we directly link to the best financial data sources.
Financials
News
Alkermes Q2 Sales Up 14 Percent
Alkermes Plc (NASDAQ:ALKS), a neuroscience-focused biopharmaceutical company, released its second quarter 2025 results on July 29, 2025. The standout news was a significant outperformance versus
Alkermes Plc EPS Soars Past Forecasts
Alkermes (NASDAQ:ALKS), a biopharmaceutical company known for its innovative drugs targeting mental health and neurological disorders, announced its Q4 2024 earnings on Feb. 12. The company reported